RNA
Avidity Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.19
−2.81%Margins
Gross margin
98.6%
EBITDA margin
-722.9%
EBIT margin
-769.3%
Net margin
-720.9%
FCF margin
-604.3%
-120.9%
Return on equity
-92.4%
Return on assets
-128.0%
Return on invested capital
0.13x
Asset turnover
-$210.5M
Cash from operations
$15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026